Reprint

Basic Research in Endocrinology: A Modern Strategy for the Development and Technologies of Personalized Medicine

Edited by
January 2022
168 pages
  • ISBN978-3-0365-2997-4 (Hardback)
  • ISBN978-3-0365-2996-7 (PDF)

This book is a reprint of the Special Issue Basic Research in Endocrinology: A Modern Strategy for the Development and Technologies of Personalized Medicine that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

The first all-Russia conference with international participation “Basic Research in Endocrinology: A Modern Strategy for the Development and Technologies of Personalized Medicine” was held in Novosibirsk on 26–27 November 2020. The purpose of this conference was to disseminate the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of endocrine disorders among various relevant specialists. The conference was intended for practicing endocrinologists, primary care physicians, medical geneticists, pediatric endocrinologists, pediatricians, and physician–scientists. The main topics included epidemiology and pathogenesis of endocrine disorders; genomic research in endocrinology; biochemical characteristics of endocrine aberrations; immunology and immunogenetics in endocrinology; cellular technologies in endocrinology; metabolomic research in endocrinology; pharmacogenetics; basic pathomorphology; high-tech care of patients with endocrine disorders; iodine-deficiency-related, autoimmune, and oncological diseases of the thyroid; modern diagnostic and therapeutic strategies for diabetes mellitus; osteoporosis and osteopenias; polyendocrinopathies; an interdisciplinary approach to the diagnosis and treatment of obesity and metabolic syndrome; hypo- and hyperparathyroidism, vitamin D; neuroendocrine disorders; reproductive health; rehabilitation of patients with endocrine disorders; health resort and spa treatments of endocrine disorders and comorbid conditions.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
diagnostic method; severity of disturbances; rheology; diabetes mellitus; erythrocyte; dielectrophoresis; diabetes mellitus; anemia of chronic disease; iron deficiency anemia; hyperlipidemia; inflammation; C-reactive protein; tumor necrosis factor-α; erythrocyte sedimentation rate; osteoporosis; fracture; menopause; population; chronic non-communicable diseases; risk factors; early IHD; abdominal obesity; blood cytokines/chemokines complex; multiplex assay; Flt3 ligand; GM-CSF; MCP-1; IL-4; maturity onset diabetes of the young type 14; diabetes mellitus; APPL1; single-nucleotide variant; population; Firmicutes; Bacteroidetes; gut microbiota; bile microbiota; gallstone patients; maturity onset diabetes of the young; MODY; diabetes mellitus; multiplex ligation-dependent probe amplification; next-generation sequencing; GCK; HNF1A; HNF4A; HNF1B; single-nucleotide variant; population; obesity; BMI; blood tests; proteomics; mass spectrometry; norepinephrine concentration in the hypothalamus; heart mass; QTL analysis; SNPs; ISIAH hypertensive rat strain; diabetes mellitus; risk factor; diabetes risk scale; diabetes risk model; type 1 diabetes mellitus; type 2 diabetes mellitus; proton spectroscopy; hippocampus; cognitive dysfunction; n/a